 |
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Saturday, November 21, 2009
|
|
|
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Saturday, November 21, 2009
|
|
Eric
H.
Kraut, MD
Professor Director, Benign Hematology James Cancer Hospital & Solove Research Institute Hematology and Oncology College of Medicine The Ohio State University |
|
Dr. Kraut earned his medical degree from the Temple University School of Medicine. He completed his residency at University of Pittsburgh and a fellowship in hematology and oncology at The Ohio State University. Dr. Kraut joined the faculty at The Ohio State University in 1975. Dr. Kraut’s research is focused on developing treatments for hemophilia. As the Director of the Benign Hematology Program, Dr. Kraut has dedicated his clinical practice to the treatment of benign blood diseases. His practice also includes lymphoma. Dr. Kraut is a member of the benign hematology team which includes Dr. Spero Cataland and Dr. Michael Stanek. He is also a member of the leukemia/lymphoma team which includes Dr. John Byrd, Dr. Kristie Blum, Dr. William Blum, Dr. Charles Eisenbeis, Dr. Sherif Farag, Dr. Thomas Lin, Dr. Guido Marcucci and Dr. Pierluigi Porcu.
|
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|